Skip to main content
. Author manuscript; available in PMC: 2012 Jun 1.
Published in final edited form as: Pharmacogenet Genomics. 2011 Jun;21(6):333–340. doi: 10.1097/FPC.0b013e3283452fec

Table 2.

LXRA gene (NR1H3) polymorphism frequencies in INVEST-GENES Case Control Data Set

Polymorphism Position Genotype
Success Rate
Minor Allele Frequency
Overall Whites Hispanics Blacks
rs11039149 (A>G) 5′ UTR/Promoter 97% 0.23 0.28 0.20 0.06
rs12221497 (G>A) 5′ UTR /Promoter 94% 0.11 0.13 0.07 0.07
rs2279238 (C>T) Exon 5 97% 0.22 0.15 0.26 0.42
rs7120118 (C>T) Intron 7 90% 0.33 0.28 0.35 0.52
rs326213 (C>A) Intron 7 93% 0.01 0.01 0.02 0.05
rs11039159 (G>T) 3′ UTR 91% 0.33 0.39 0.29 0.13
rs10501321 (G>T) 3′ UTR 92% 0.36 0.30 0.37 0.59